Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Validation of Post-Operative Residual Contrast Enhancing Tumor Volume as an Independent Prognostic Factor for Overall Survival in Newly Diagnosed GlioblastomaNeuro-oncology 2018 Apr 05;[EPub Ahead of Print], BM Ellingson, LE Abrey, SJ Nelson, TJ Kaufmann, J Garcia, O Chinot, F Saran, R Nishikawa, R Henriksson, WP Mason, W Wick, N Butowski, KL Ligon, ER Gerstner, H Colman, J de Groot, S Chang, I Mellinghoff, RJ Young, BM Alexander, R Colen, JW Taylor, I Arrillaga-Romany, A Mehta, RY Huang, WB Pope, D Reardon, T Batchelor, M Prados, E Galanis, PY Wen, TF Cloughesy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.